Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.

Slides:



Advertisements
Similar presentations
Sexually Transmitted Disease Surveillance 2012 Division of STD Prevention 2012 Data.
Advertisements

STDs in Women and Infants Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
Update on Gonococcal Resistance in the United States Susan A. Wang, MD, MPH Division of STD Prevention National Center for HIV, STD, and TB Prevention.
Current Epidemiology of Selected STDs Prepared by Bradley Stoner, MD, PhD, Medical Director and Deloris Rother, MPH, Project Manager St. Louis STD/HIV.
STDs. Chlamydia—Rates by Sex, United States, 1990–2010 NOTE: As of January 2000, all 50 states and the District of Columbia have regulations that require.
Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention 2011 Data.
Steven J Shapiro Infertility Prevention Project Coordinator Program and Training Branch Infertility Prevention Project Region I Wells, Maine June 6-7,
Chlamydia Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
STD Surveillance 2001 Adapted from CDC by Jill Gallin, CPNP Assistant Professor of Clinical Nursing.
Gonococcal Isolate Surveillance Project (GISP)
Gonorrhea Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
Syphilis Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Syphilis Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Chlamydia Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Gonorrhea Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Gonorrhea Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
Denver Prevention Training Center Denver Public Health Department Pieces of the Puzzle Conference Great Falls November 21, 2013.
CHLAMYDIA Sexually Transmitted Disease Surveillance 2010 Division of STD Prevention.
All Slides Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Steven.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
Application of an Epi Profile: Gonorrhea in the U.S. Region V Gonorrhea Control Meeting.
Gonorrhea in New York City Epidemiology, Disease Control Activities, and Challenges Presented by: Julia A. Schillinger, MD, MSc CAPT USPHS Bureau of STD.
Gonorrhea Epidemiology and Control Efforts in Louisiana Lisa Longfellow, MPH October 14, 2009.
All Slides Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.
Gonorrhea in California Gonorrhea Control in Region IX: Optimizing Strategies to Reduce Morbidity Phoenix, AZ January 14, 2010 Michael C. Samuel, Dr.P.H.
All Slides Sexually Transmitted Disease Surveillance 2006 Division of STD Prevention.
Sexually Transmitted Disease (STD) Surveillance Report, 2007 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Gonorrhea Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
Chlamydia Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
All Slides Sexually Transmitted Disease Surveillance 2002 Division of STD Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
GONORRHEA Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
South Dakota STD Update Webinar – August 15, 2012 Kees Rietmeijer, MD, PhD Medical Director, Denver STD/HIV Prevention Training Center.
All Slides Sexually Transmitted Disease Surveillance 2001 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Sexually Transmitted Disease Surveillance 2010 Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
All Slides Sexually Transmitted Disease Surveillance 1999 Division of STD Prevention.
All Slides Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Current Epidemiology of Selected STDs Helen Burnside, MS NNPTC National Coordination Center Denver Prevention Training Center.
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
Syphilis Sexually Transmitted Disease Surveillance 1999 Division of STD Prevention.
Chlamydia Sexually Transmitted Disease Surveillance 2004 Division of STD Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
All Slides Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Gonorrhea Sexually Transmitted Disease Surveillance 2006 Division of STD Prevention.
22 February 2016 GRASP (Gonococcal Resistance to Antimicrobials Surveillance Programme) Catherine Ison Sexually Transmitted Bacteria Reference Laboratory.
Antimicrobial Resistance Surveillance (AMR Surveillance)
STDs in Racial and Ethnic Minorities Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
All Slides Sexually Transmitted Disease Surveillance 2005 Division of STD Prevention.
STDs Among Men Who Have Sex with Men Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2005 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2004 Division of STD Prevention.
GONORRHEA Sexually Transmitted Disease Surveillance 2010 Division of STD Prevention.
Sexually Transmitted Infections Bacterial Viral Parasitic.
Gonorrhea Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
Lizzi Torrone, MSPH, PhD Lead, Surveillance & Special Studies Team
Gonococcal Isolate Surveillance Project (GISP)
Sexually Transmitted Disease Surveillance 2009
Gonorrhea Epidemiology and Control Efforts in Louisiana
Gonorrhea Sexually Transmitted Disease Surveillance 2010
Presentation transcript:

Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention

Gonorrhea—Rates, United States, 1941– Fig 16. SR

Gonorrhea—Rates by Sex, United States, 1991– Fig 17. SR

Gonorrhea—Rates by Region, United States, 2002– Fig 18. SR

Gonorrhea—Rates by State, United States and Outlying areas, 2011 NOTE: The total rate of gonorrhea for the United States and outlying area (Guam, Puerto Rico, and Virgin Islands) was per 100,000 population Fig 19. SR

Gonorrhea—Rates by County, United States, Fig 20. SR

Gonorrhea—Rates by Age and Sex, United States, Fig 21. SR

Gonorrhea—Rates by Age Among Women Aged 15–44 Years, United States, 2002– Fig 22. SR

Gonorrhea—Rates by Age Among Men Aged 15–44 Years, United States, 2002– Fig 23. SR

Gonorrhea—Rates by Race/Ethnicity, United States, 2002– Fig 24. SR

Gonorrhea—Cases by Reporting Source and Sex, United States, 2002– Fig 25. SR

Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2011 *HMO=health maintenance organization; HD=health department NOTE: These categories represent 66.5% of cases with a known reporting source. Of all cases, 11.7% has a missing or unknown reporting source Fig 26. SR

Proportion MSM*, MSW*, and Women Among Interviewed † Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2011 *MSM=men who have sex with men; MSW=men who have sex with women only. †SSuN interviews conducted in a randomly selected sample of the patient population with gonorrhea (n=4,540). ‡California data excludes San Francisco. NOTE: See Appendix for included jurisdictions within each state Fig 27. SR

Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2011 *States/areas had incomplete data or reported gonorrhea positivity data on fewer than 500 women aged years in Fig 28. SR

Location of Participating Sentinel Sites and Regional Laboratories, Gonococcal Isolate Surveillance Project (GISP), United States, 2011 *NOTE: The Austin site is a regional laboratory only Fig 29. SR

Distribution of Minimum Inhibitory Concentrations (MICs) of Ceftriaxone Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2007– Fig 30. SR

Distribution of Minimum Inhibitory Concentrations (MICs) of Cefixime Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2009–2011 NOTE: Isolates were not tested for cefixime susceptibility in 2007 and Fig 31. SR

Distribution of Minimum Inhibitory Concentrations (MICs) of Azithromycin Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2007– Fig 32. SR

Percentage of Neisseria gonorrhoeae Isolates that are Ciprofloxacin-Resistant by Sex of Sex Partner, Gonococcal Isolate Surveillance Project (GISP), 1995–2011 *MSM=men who have sex with men; MSW=men who have sex with women only Fig 33. SR

Penicillin, Tetracycline, and Ciprofloxacin Resistance Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2011 NOTE: PenR = penicillinase producing Neisseria gonorrhoeae and chromosomally mediated penicillin-resistant N. gonorrhoeae; TetR = chromosomally and plasmid mediated tetracycline-resistant N. gonorrhoeae; and QRNG = quinolone-resistant N. gonorrhoeae Fig 34. SR

Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP), 1988–2011 NOTE: For 2011, “Other” includes no therapy (1.2%), azithromycin 2g (2.3%), and other less frequently used drugs Fig 35. SR